Mirae Asset Global ETFs Holdings
LGND icon

Mirae Asset Global ETFs Holdings’s Ligand Pharmaceuticals LGND Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.81M Buy
9,077
+41
+0.5% +$8.11K ﹤0.01% 1217
2025
Q4 		$1.71M Buy
9,036
+167
+2% +$32.1K ﹤0.01% 1229
2025
Q3 		$1.57M Sell
8,869
-1,587
-15% -$236K ﹤0.01% 1252
2025
Q2 		$1.19M Sell
10,456
-204
-2% -$21.8K ﹤0.01% 1363
2025
Q1 		$1.12M Buy
10,660
+809
+8% +$91.5K ﹤0.01% 1444
2024
Q4 		$1.06M Buy
9,851
+554
+6% +$62.6K ﹤0.01% 1515
2024
Q3 		$931K Buy
9,297
+1,162
+14% +$117K ﹤0.01% 1582
2024
Q2 		$685K Buy
+8,135
New +$647K ﹤0.01% 1667

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's LGND Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Ligand Pharmaceuticals (LGND) stake by 0.45% in Q1 2026, buying an estimated $8.11K and bringing the position to 9,077 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1217.

Mirae Asset Global ETFs Holdings first reported a position in LGND in Q2 2024 and has held it in 8 quarters since. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 9,077 shares of Ligand Pharmaceuticals worth $1.81M as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 41 Ligand Pharmaceuticals shares in Q1 2026, an estimated $8.11K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1217 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Ligand Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.